LEVLITE Drug Patent Profile
✉ Email this page to a colleague
When do Levlite patents expire, and what generic alternatives are available?
Levlite is a drug marketed by Bayer Hlthcare and is included in one NDA.
The generic ingredient in LEVLITE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVLITE?
- What are the global sales for LEVLITE?
- What is Average Wholesale Price for LEVLITE?
Summary for LEVLITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 5 |
| Patent Applications: | 277 |
| DailyMed Link: | LEVLITE at DailyMed |
US Patents and Regulatory Information for LEVLITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | LEVLITE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-21 | 020860-001 | Jul 13, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer Hlthcare | LEVLITE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 020860-002 | Jul 13, 1998 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
